资讯

肝癌治疗手段有限,为探索新疗法,研究人员开展了氧化钇纳米颗粒( Y 2?O3? NPs)对 Hep-G2 肝癌细胞影响的研究。结果发现 Y 2?O3? NPs 能显著抑制细胞活力、诱导细胞凋亡等。这为肝癌治疗提供了新方向,具有重要意义。
Ascentage Pharma Group International’s AAPG share price has dipped by 6.94%, which has investors questioning if this is right ...
美国马里兰州罗克维尔市和中国苏州2025年3月26日 /美通社/ -- 致力于在血液肿瘤等领域开发创新药物的领先的生物医药企业——亚盛医药(纳斯达克代码:AAPG;香港联交所代码:6855)今日宣布,公司共有五项临床前研究进展入选2025年美国癌症研究协会(AACR)年会。此次会议将于 2025 年 4 月 25 日至 30 日在美国芝加哥举行。 本次将要展示的数据涉及公司五个品种,包括:原创1类 ...
4月11日,亚盛医药 (AAPG)的股票在盘中上涨了3.39%,截至22:00时,报18.3美元/股,交易量达到了36.57万美元,总市值也随之攀升至15.93亿美元。这一切的背后,又隐藏着怎样的市场逻辑与创新驱动?
Nature, 6867, 45-53. [31] Maier, Gluba, Bernier, Turner, Mohammad, Guise, Sutherland, Thorner, and Scrable (2004) Modulation of mammalian life span by the short isoform of p53. Genes Dev, 3, 306-19.
The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
The Outer Worlds 2 is set to bring us more Obsidian RPG goodness this year in a follow-up to the first space-faring adventure that released back in 2019. Officially set to arrive sometime in 2025 ...
为解决结直肠癌(CRC)放疗抵抗这一临床难题,研究人员开展了 PRKCSH 在 CRC 放疗抵抗中作用及机制的研究。结果发现 PRKCSH 可经 IRE1α/XBP1s 通路促进 DNA 损伤修复,导致放疗抵抗。该研究为 CRC 放疗增敏提供新靶点,有望改善治疗效果。
After seven years on the market, 150 million systems, and more than 1 billion games sold for the original Switch, Nintendo is finally ushering in its next console--the Nintendo Switch 2.
Death Stranding 2 has been confirmed for PS5, and Kojima Productions is yet to reveal whether it will arrive on other platforms. When Death Stranding launched in 2019, it did so as a PS4 exclusive.
BCL Enterprises Ltd. key Products/Revenue Segments include Income From Sale Of Share & Securities, Interest and Others for the year ending 31-Mar-2024.For the quarter ended 31-12-2024, the company has ...
The data convincingly show that the transcription factor Sp1 regulates ephrin-mediated axon guidance in the spinal cord. Although the authors show that Sp1 and its co-activators p300 and CBP are ...